Biotime Inc Insider Profile
4 Followers
Biotime Inc, Previous 10% Owner at Insight Molecular Diagnostics, holds 6.04M shares in Insight Molecular Diagnostics (Ticker: IMDX), holds 21.82M shares in Asterias Biotherapeutics (Ticker: AST). Most recently, Biotime Inc Sold ― shares of Insight Molecular Diagnostics on Jan 06, 2020 for an estimated value of $5.12M.
Biotime Inc's Trading History
| IMDXInsight Molecular Diagnostics | Jan 06, 2020 | Previous 10% Owner | Informative Sell | 5.12M | $12.93M | |
| ASTAsterias Biotherapeutics | Mar 02, 2016 | ― | Uninformative Sell | ― | $20.62M |
You May Also Like
Biotime Inc insider profile FAQ
What is the percentage of profitable transactions made by Biotime Inc?
The percentage of profitable transactions made by Biotime Inc is 67%.
What is the average return per transaction made by Biotime Inc?
The average return per transaction made by Biotime Inc is 18.40%.
What stocks does Biotime Inc hold?
Biotime Inc holds: IMDX, AST stocks.
What was Biotime Inc’s latest transaction?
Biotime Inc’s latest transaction was an Informative Sell of $5.12M.
What was Biotime Inc's most profitable transaction?
Biotime Inc’s most profitable transaction was an Informative Sell of IMDX stock on September 13, 2019. The return on the trade was 32.80%.
What is Biotime Inc's role in Insight Molecular Diagnostics?
Biotime Inc's role in Insight Molecular Diagnostics is Previous 10% Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
